GILD: Gilead Sciences, Inc. Stock

by  •  • Comments Off on GILD: Gilead Sciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 80,778.67
Enterprise Value ($M) 103,596.67
Book Value ($M) 17,455.00
Book Value / Share 14.00
Price / Book 4.63
NCAV ($M) -26,087.00
NCAV / Share -20.92
Price / NCAV -3.10

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 0.72
Current Ratio 0.98

Balance Sheet (mrq) ($M)
Current Assets 12,750.00
Assets 56,292.00
Liabilities 38,837.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 27,116.00
Operating Income 9,893.00
Net Income 5,665.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 8,006.00
Cash from Investing -2,265.00
Cash from Financing -5,125.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 8.97 -0.19
02-09 13G/A Capital World Investors 6.70 21.48
01-24 13G/A BlackRock Inc. 9.90 -6.66

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-06 812,019 5,501,488 14.76
2024-05-03 600,807 7,822,720 7.68
2024-05-02 606,226 2,181,792 27.79
2024-05-01 678,867 2,946,316 23.04

(click for more detail)

Similar Companies
FUSN – Fusion Pharmaceuticals Inc. GBIO – Generation Bio Co.
GERN – Geron Corporation GLUE – Monte Rosa Therapeutics, Inc.
GOSS – Gossamer Bio, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Gilead Sciences